SS
CABA icon

Steve Schonfeld’s Cabaletta Bio CABA Stock Holding History

Steve Schonfeld’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-28,172
Closed -$75.8K – 2643
2026
Q1 		$75.8K Sell
28,172
-1,175,898
-98% -$3.27M ﹤0.01% 1923
2025
Q4 		$2.64M Buy
1,204,070
+159,901
+15% +$396K 0.01% 779
2025
Q3 		$2.44M Sell
1,044,169
-440,667
-30% -$756K 0.01% 931
2025
Q2 		$2.26M Sell
1,484,836
-177,565
-11% -$277K 0.02% 917
2025
Q1 		$2.3M Buy
+1,662,401
New +$3.54M 0.01% 892
2024
Q3 		– Sell
-194,037
Closed -$1.45M – 2068
2024
Q2 		$1.45M Sell
194,037
-123,483
-39% -$1.51M 0.01% 1046
2024
Q1 		$5.42M Buy
317,520
+65,905
+26% +$1.41M 0.04% 618
2023
Q4 		$5.71M Buy
+251,615
New +$4.23M 0.04% 494

Other funds holding CABA

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Steve Schonfeld's CABA Position: Q2 2026 in Review

Steve Schonfeld sold out of Cabaletta Bio (CABA) in Q2 2026, closing a stake of 28,172 shares — an estimated $75.8K sold.

Steve Schonfeld first reported a position in CABA in Q4 2023 and held it in 8 quarters. The position peaked at $5.71M in Q4 2023. 139 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • Steve Schonfeld reported no remaining Cabaletta Bio position as of Q2 2026 after selling out during the quarter.
  • Steve Schonfeld sold 28,172 Cabaletta Bio shares in Q2 2026, an estimated $75.8K.
  • Steve Schonfeld first reported a position in Cabaletta Bio in Q4 2023 and held it in 8 quarters.
  • Steve Schonfeld's Cabaletta Bio position peaked at $5.71M in Q4 2023.
  • 139 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.